Diazoxide

• 

  Subject Areas on Research

  • Bioenergetic defect associated with mKATP channel opening in a mouse model carrying a mitofusin 2 mutation. 
  • Diazoxide restores beta3-adrenergic receptor function in diet-induced obesity and diabetes. 
  • Diuretic exposure in premature infants from 1997 to 2011. 
  • Effects of diazoxide and beta adrenergic drugs on spontaneous and induced uterine activity in the pregnant baboon. 
  • Nonemergency use of slow infusions of diazoxide. 
  • Overexpression of a modified human malonyl-CoA decarboxylase blocks the glucose-induced increase in malonyl-CoA level but has no impact on insulin secretion in INS-1-derived (832/13) beta-cells. 
  • Prevalence and safety of diazoxide in the neonatal intensive care unit. 
  • The effects of intra-venous diazoxide, a non-diuretic thiazide, upon blood pressure, electrolyte, and uric acid excretion. 
  • The inhibitory effect of diazoxide in normal term labor. 
  • The relaxant effect of diazoxide on isolated gravid and nongravid human myometrium. 
  • The relaxant effect of diazoxide on nongravid human myometrium in vivo. 
  • Vasodilator administration in the presence of beta-adrenergic blockade.